Royalty Pharma plc (RPRX) has 20 détenteurs institutionnels et initiés connus enregistrés. Le plus grand détenteur est ADAGE CAPITAL PARTNERS GP, L.L.C. avec 38,815,330 actions. Parmi les autres détenteurs notables GG 1978 SICAF SIF S.A. et GG 1978 SICAF SIF S.A. - GG Strategic.
Au cours des 12 derniers mois, les initiés ont effectué 80 transactions sur RPRX l'action — 41 achats (d'une valeur de $187.39K) et 28 ventes (d'une valeur de $20.79M). Les achats d'initiés ont dépassé les ventes durant cette période, ce qui peut signaler une confiance dans les perspectives de l'entreprise.
RPRX Participations des Initiés
Principal Actionnaire
ADAGE CAPITAL PARTNERS GP, L.L.C.
38,815,330 actions
Achats (12 mois)
41
$187.39K valeur
Ventes (12 mois)
28
$20.79M valeur
Activité de transactions (12 mois)
Principaux actionnaires initiés
| # |
Nom |
Rôle |
Actions détenues |
Dernière déclaration |
Taille relative |
| 1 |
Adage Capital Partners Gp, L.l.c. |
10 Percent Owner |
38,815,330 |
2020-12-18 |
|
| 2 |
Gg 1978 Sicaf Sif S.a. |
Officer |
22,235,310 |
2022-09-16 |
|
| 3 |
Gg 1978 Sicaf Sif S.a. - Gg Strategic |
Officer |
21,426,170 |
2022-09-22 |
|
| 4 |
Efficacy Capital, Ltd. |
10 Percent Owner |
2,658,936 |
2009-12-21 |
|
| 5 |
Avara Management Ltd |
10 Percent Owner |
2,477,520 |
2024-01-03 |
|
| 6 |
Oliveira Steven Michael |
10 Percent Owner |
1,315,672 |
2011-04-26 |
|
| 7 |
Legorreta Pablo G. |
CEO, Chairman of the Board |
1,098,783 |
2026-02-13 |
|
| 8 |
Hite Christopher |
EVP & Vice Chairman |
685,136 |
2026-02-13 |
|
| 9 |
Reddoch James F. |
EVP & Chief Scientific Officer |
478,870 |
2022-09-30 |
|
| 10 |
Riggs Rory B |
Director |
270,000 |
2024-02-22 |
|
| 11 |
Norden Gregory |
Director |
194,848 |
2025-08-11 |
|
| 12 |
Desouza Errol B |
Director |
81,352 |
2025-05-14 |
|
| 13 |
Bassler Bonnie L |
Director |
73,947 |
2026-03-31 |
|
| 14 |
Fernandez Henry A |
Director |
65,324 |
2025-06-30 |
|
| 15 |
Love Ted W |
Director |
53,848 |
2025-05-14 |
|
| 16 |
Engelbert Catherine M. |
Director |
51,128 |
2025-05-15 |
|
| 17 |
Hodgson David C |
Director |
33,328 |
2025-05-14 |
|
| 18 |
Coyne Terrance P. |
EVP & CFO |
32,916 |
2026-04-02 |
|
| 19 |
Lloyd George W. |
EVP, Investments & CLO |
30,654 |
2025-12-19 |
|
| 20 |
Masterson Nola E |
Director |
27,779 |
2018-01-31 |
|
Transactions récentes (12 derniers mois)
| Date |
Nom |
Rôle |
Type |
Actions |
Prix |
Valeur |
| 2026-04-01 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
32,916 |
$48.33 |
$1.59M |
| 2026-03-31 |
Bassler Bonnie L |
Director |
Attribution de RSU |
815 |
$45.98 |
$37.47K |
| 2026-03-23 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
1,875 |
$45.53 |
$85.37K |
| 2026-03-02 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
583 |
$47.01 |
$27.41K |
| 2026-02-23 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
1,875 |
$45.32 |
$84.97K |
| 2026-02-11 |
Urist Marshall |
EVP, Research & Investments |
Attribution de RSU |
19,970 |
- |
- |
| 2026-02-11 |
Coyne Terrance P. |
EVP & CFO |
Attribution de RSU |
26,626 |
- |
- |
| 2026-02-11 |
Hite Christopher |
EVP & Vice Chairman |
Attribution de RSU |
26,626 |
- |
- |
| 2026-02-11 |
Legorreta Pablo G. |
CEO, Chairman of the Board |
Attribution de RSU |
157,828 |
- |
- |
| 2026-02-04 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
1,087 |
$43.29 |
$47.06K |
| 2026-02-03 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
6,195 |
$42.84 |
$265.41K |
| 2026-02-02 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
5,843 |
$42.08 |
$245.9K |
| 2026-01-30 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$41.09 |
$821.81K |
| 2026-01-23 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$40.26 |
$805.11K |
| 2026-01-20 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
3,750 |
$39.35 |
$147.56K |
| 2026-01-16 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$39.52 |
$790.35K |
| 2026-01-09 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$40.78 |
$815.63K |
| 2026-01-01 |
Mcgivern Arthur Richard |
EVP, Investments & Gc |
Inconnu |
706,393 |
- |
- |
| 2026-01-02 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$38.48 |
$769.65K |
| 2026-01-02 |
Coyne Terrance P. |
EVP & CFO |
Vente Informative |
3,750 |
$38.42 |
$144.06K |
| 2025-12-31 |
Bassler Bonnie L |
Director |
Attribution de RSU |
967 |
$38.74 |
$37.46K |
| 2025-12-26 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$39.32 |
$786.38K |
| 2025-12-19 |
Urist Marshall |
EVP, Research & Investments |
Vente Informative |
20,000 |
$38.38 |
$767.58K |
| 2025-12-18 |
Lloyd George W. |
EVP, Investments & CLO |
Vente Informative |
30,654 |
$38.50 |
$1.18M |
| 2025-12-17 |
Lloyd George W. |
EVP, Investments & CLO |
Vente Informative |
79,346 |
$38.57 |
$3.06M |
Les autres consultent aussi
